no statement of use filed
on 23 May 2022
Last Applicant/ Owned by
885 West Georgia Street, Ste. 2150
Vancouver, B.C.
V6C3E8
Serial Number
90461170 filed on 12th Jan 2021
Registration Number
N/A
Correspondent Address
Alyssa M. Worsham
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); Pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, prRead More
Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); Pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medical reagents; Medical diagnostic reagents, assays, and test kits for testing of body fluids; Cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely, cancer, for medical use
Pharmaceutical research and development; Development of pharmaceutical preparations and drugs; Development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; Scientific research and development; Scientific laboratory services; Medical laboratory services; Conducting clinical trials for others; Conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes
Medical services; Medical testing services; DNA screening and analysis services for medical purposes
No 90461170
No Service Mark
No 60188-TM1001
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 23rd May 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 23rd May 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 19th Oct 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 24th Aug 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 24th Aug 2021 | PUBLISHED FOR OPPOSITION |
| 04th Aug 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 22nd Jul 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 22nd Jul 2021 | EXAMINER'S AMENDMENT ENTERED |
| 22nd Jul 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 22nd Jul 2021 | EXAMINERS AMENDMENT E-MAILED |
